Active Not Recruiting NA INTERVENTIONAL 1-arm NCT03814252

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-TULSA for Localized Prostate Cancer (PRO-TULSA-PC)

Prospective Clinical Safety and Efficacy Study of Lesion-targeted MRI-guided Transurethral Ultrasound Ablation for Localized Prostate Cancer

Sponsor: Turku University Hospital

Conditions Localized Prostate Cancer

Interventions MRI-TULSA

Updated 9 times since 2019 Last updated: Sep 16, 2025 Started: Oct 30, 2018 Primary completion: Dec 31, 2023 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Localized Prostate Cancer, this trial is ongoing. The trial is conducted by Turku University Hospital and has accumulated 9 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

9 versions recorded

Oct 2025 — Present [monthly]

Active Not Recruiting NA
Sep 2024 — Oct 2025 [monthly]

Active Not Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Active Not Recruiting NA
May 2024 — Jul 2024 [monthly]

Active Not Recruiting NA
Jun 2022 — May 2024 [monthly]

Active Not Recruiting NA

Status: Recruiting → Active Not Recruiting

▶ Show 4 earlier versions

Jun 2021 — Jun 2022 [monthly]

Recruiting NA
Jan 2021 — Jun 2021 [monthly]

Recruiting NA
Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Feb 2019 — Apr 2020 [monthly]

Recruiting NA

First recorded

Oct 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Turku University Hospital

Data source: Turku University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Turku, Finland